SCHEMBL26445758

SCHEMBL26445758

COC(=O)CCCOC1OC(COC(=O)c2ccccc2)C(OC(=O)c2ccccc2)C(OC(=O)c2ccccc2)C1OC(=O)c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTPN1 P18031 9/20 0.47
▸ USP2 O75604 2/20 0.46
▸ MEN1 O00255 1/20 0.46
▸ POLB P06746 1/20 0.46
▸ KMT2A Q03164 1/20 0.46
▸ F11 P03951 2/20 0.43
▸ TMPRSS2 O15393 1/20 0.43
▸ PDE5A O76074 1/20 0.43
▸ CA1 P00915 1/20 0.43
▸ CA2 P00918 1/20 0.43
▸ HMGCR P04035 1/20 0.43
▸ CYP1A2 P05177 1/20 0.43
▸ LCK P06239 1/20 0.43
▸ FYN P06241 1/20 0.43
▸ HSPD1 P10809 1/20 0.43
▸ CYP2C9 P11712 1/20 0.43
▸ CA6 P23280 1/20 0.43
▸ TBXAS1 P24557 1/20 0.43
▸ MAPK3 P27361 1/20 0.43
▸ MAPK1 P28482 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26445770 1.00 PTPN1 (0.47) PTPN1USP2MEN1POLBKMT2A
SCHEMBL26443696 0.90 MEN1 (0.41) PTPN1USP2MEN1POLBKMT2A
SCHEMBL32675078 0.89 PTPN1 (0.50) PTPN1USP2MEN1POLBKMT2A
SCHEMBL22946818 0.89 PTPN1 (0.50) PTPN1USP2MEN1POLBKMT2A
SCHEMBL20738379 0.89 PTPN1 (0.49) PTPN1USP2MEN1POLBKMT2A
SCHEMBL16905548 0.88 USP2 (0.44) PTPN1USP2MEN1POLBKMT2A
SCHEMBL12248474 0.88 PTPN1 (0.48) PTPN1USP2MEN1POLBKMT2A
SCHEMBL15344334 0.88 PTPN1 (0.48) PTPN1USP2MEN1POLBKMT2A
SCHEMBL12248477 0.88 PTPN1 (0.48) PTPN1USP2MEN1POLBKMT2A
SCHEMBL13117382 0.88 PTPN1 (0.48) PTPN1USP2MEN1POLBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230134986-A1 GLUCOSE TRIPTOLIDE CONJUGATES AND USES THEREOF SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY, CHINESE ACADEMY OF SCIENCES (CN) 2023-05-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230134986-A1 GLUCOSE TRIPTOLIDE CONJUGATES AND USES THEREOF SLC2A1, SLC2A9, GID4 PTPN1 2524/4885USP2 1955/4885MEN1 3088/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback